Approximately 50% of AD patients exhibit alpha-synuclein pathology, while up to 50% of PD patients with dementia have amyloid-beta proteins and neurofibrillary tangles that are sufficient enough for secondary AD diagnosis (Irwin et al., 2013; Lim et al., 2019). The gene discussed is SNCA; the disease is Alzheimer disease.